Extracellular miR-224 as a prognostic marker for clear cell renal cell carcinoma

被引:49
|
作者
Fujii, Nakanori [1 ]
Hirata, Hiroshi [1 ,2 ]
Ueno, Koji [3 ]
Mori, Junichi [1 ]
Oka, Shintaro [1 ]
Shimizu, Kosuke [1 ]
Kawai, Yoshihisa [1 ]
Inoue, Ryo [1 ]
Yamamoto, Yoshiaki [1 ]
Matsumoto, Hiroaki [1 ]
Shimabukuro, Tomoyuki [1 ,4 ]
Udoh, Koichi [5 ]
Hoshii, Yoshinobu [6 ]
Dahiya, Rajvir [7 ,8 ]
Matsuyama, Hideyasu [1 ]
机构
[1] Yamaguchi Univ, Grad Sch Med, Dept Urol, Ube, Yamaguchi 7558505, Japan
[2] Ube Mem Hosp, Dept Urol, Ube, Yamaguchi 7550051, Japan
[3] Yamaguchi Univ, Ctr Regenerat Med, Grad Sch Med, Ube, Yamaguchi 7558505, Japan
[4] Ube Kosan Cent Hosp, Dept Urol, Ube, Yamaguchi 7550151, Japan
[5] Yamaguchi Univ, Inst Biomed Res & Educ, Sci Res Ctr, Ube, Yamaguchi 7558505, Japan
[6] Yamaguchi Univ, Dept Diagnost Pathol, Ube, Yamaguchi 7558505, Japan
[7] San Francisco VA Med Ctr, Dept Urol, San Francisco, CA 94121 USA
[8] Univ Calif San Francisco, San Francisco, CA 94121 USA
基金
美国国家卫生研究院;
关键词
microRNA; miR-224; exosome; clear cell renal cell carcinoma; COLORECTAL-CANCER; EXOSOMAL MICRORNA; PROSTATE-CANCER; PROGRESSION; INVASION; MICROVESICLES; EXPRESSION; BIOMARKERS; GUIDELINES; BIOLOGY;
D O I
10.18632/oncotarget.22436
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Exosome-miRNAs (exo-miR) have recently been identified as modulators of cancer progression and distant metastasis. We previously found that intracellular miR-224 is up-regulated and significantly related to cancer invasion and metastasis in clear cell renal cell carcinoma (ccRCC). We therefore investigated the role of exosome miR-224 in ccRCC and explored the interaction between intra-and extracellular miR-224 in renal cell carcinoma. To validate the method for isolating exosomes from blood samples or cell culture media, we examined exosome morphology using transmission electron microscope (TEM). We investigated the relationship between exo-miR-224 expression and patient prognosis in 108 ccRCC patients. We isolated exosomes from a metastatic renal cancer cell line and tested their effects on a primary renal cancer cell line with several functional analyses. We found that the high expression level exo-miR-224 group has significantly shorter progression-free survival, cancer-specific survival, and overall survival compared with the low expression group. In multivariate analysis, a high level of exo-miR-224 was a significant risk factor related to all prognoses investigated. After adding exosomes from a metastatic RCC cell line to a primary RCC cell line, cell proliferation and invasion were increased while the percentage of apoptotic cells was significantly decreased. Intracellular levels of miR-224 were significantly up-regulated in the primary renal cancer cell line. Extracellular miR-224 in exosomes impacts on patient prognosis and is a potential prognostic biomarker for ccRCC patients.
引用
收藏
页码:109877 / 109888
页数:12
相关论文
共 50 条
  • [1] MiR-210 Is a Prognostic Marker in Clear Cell Renal Cell Carcinoma
    Ibrahim, Rania
    Samaan, Sara
    Khella, Heba
    Ding, Qiang
    Evans, Andrew
    Lianidou, Evi
    Gabril, Manal
    Ktylov, Setgey
    Jewett, Michael
    Bjarnason, Georg
    Yousef, George
    [J]. LABORATORY INVESTIGATION, 2015, 95 : 231A - 231A
  • [2] miR-210 Is a Prognostic Marker in Clear Cell Renal Cell Carcinoma
    Samaan, Sara
    Khella, Heba W. Z.
    Girgis, Andrew
    Scorilas, Andreas
    Lianidou, Evi
    Gabril, Manal
    Krylov, Sergey N.
    Jewett, Michael
    Bjarnason, Georg A.
    El-said, La
    Yousef, George M.
    [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2015, 17 (02): : 136 - 144
  • [3] MiR-210 Is a Prognostic Marker in Clear Cell Renal Cell Carcinoma
    Ibrahim, Rania
    Samaan, Sara
    Khella, Heba
    Ding, Qiang
    Evans, Andrew
    Lianidou, Evi
    Gabril, Manal
    Krylov, Sergey
    Jewett, Michael
    Bjarnason, Georg
    Yousef, George
    [J]. MODERN PATHOLOGY, 2015, 28 : 231A - 231A
  • [4] miR-10b is a prognostic marker in clear cell renal cell carcinoma
    Khella, Heba W. Z.
    Daniel, Nicole
    Youssef, Leza
    Scorilas, Andreas
    Nofech-Mozes, Roy
    Mirham, Lorna
    Krylov, Sergey N.
    Liandeau, Evi
    Krizova, Adriana
    Finelli, Antonio
    Cheng, Yufeng
    Yousef, George M.
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2017, 70 (10) : 854 - 859
  • [5] miR-224/miR-141 ratio as a novel diagnostic biomarker in renal cell carcinoma
    Chen, Xuanyu
    Lou, Ning
    Ruan, Anming
    Qiu, Bin
    Yan, Yun
    Wang, Xuegang
    Du, Quansheng
    Ruan, Hailong
    Han, Weiwei
    Wei, Haibin
    Yang, Hongmei
    Zhang, Xiaoping
    [J]. ONCOLOGY LETTERS, 2018, 16 (02) : 1666 - 1674
  • [6] Low Expression of miR-126 Is a Prognostic Marker for Metastatic Clear Cell Renal Cell Carcinoma
    Khella, Heba W. Z.
    Scorilas, Andreas
    Mozes, Roy
    Mirham, Lorna
    Lianidou, Evi
    Krylov, Sergey N.
    Lee, Jason Y.
    Ordon, Michael
    Stewart, Robert
    Jewett, Michael A. S.
    Youseff, George M.
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2015, 185 (03): : 693 - 703
  • [7] TEK is a novel prognostic marker for clear cell renal cell carcinoma
    Ha, M.
    Son, Y. R.
    Kim, J.
    Park, S. M.
    Hong, C. M.
    Choi, D.
    Kang, W.
    Kim, J. H.
    Lee, K. J.
    Park, D.
    Han, M. E.
    Oh, S. O.
    Lee, D.
    Kim, Y. H.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (04) : 1451 - 1458
  • [8] The miR21/10b ratio as a prognostic marker in clear cell renal cell carcinoma
    Fritz, Helena K. M.
    Lindgren, David
    Ljungberg, Borje
    Axelson, Hakan
    Dahlback, Bjorn
    [J]. EUROPEAN JOURNAL OF CANCER, 2014, 50 (10) : 1758 - 1765
  • [9] miR-224 is an early-stage biomarker of hepatocellular carcinoma with miR-224 and miR-125b as prognostic biomarkers
    Yang, Lichao
    Wei, Chunmeng
    Li, Yasi
    He, Xiao
    He, Min
    [J]. BIOMARKERS IN MEDICINE, 2020, 14 (15) : 1485 - 1500
  • [10] Lactate Dehydrogenase A is a potential prognostic marker in clear cell renal cell carcinoma
    Hala Girgis
    Olena Masui
    Nicole MA White
    Andreas Scorilas
    Fabio Rotondo
    Annetta Seivwright
    Manal Gabril
    Emily R Filter
    Andrew HA Girgis
    Georg A Bjarnason
    Michael AS Jewett
    Andrew Evans
    Sahar Al-Haddad
    KW Michael Siu
    George M Yousef
    [J]. Molecular Cancer, 13